A preliminary study has revealed that athletes with ADHD may be at greater risk for experiencing persistent anxiety and depression after a concussion.
Scientists have demonstrated how variations in a gene linked to anxiety and depression could affect a patient’s response to treatment.
The link between emotional processing and our immune responses – as seen in the placebo effect – could lead to new avenues for treating psychiatric diseases, according to research.
On-going research reveals that deep brain stimulation may help individuals with chronic depression and could help them regain their lives.
Researchers reveal that post-traumatic stress disorder, anxiety and some types of inflammation may be alleviated by cannabis-like drugs.
In an international collaboration, researchers have determined that psychiatric disorders may have important molecular similarities that are not reflected in current diagnostic categories.
Scientists have identified novel genes associated with a specific form of schizophrenia, which could potentially aid diagnosis and development of treatments.
Over a third of adults in the USA may be unknowingly using prescription medications that could increase the risk of depression and suicide.
A novel study reveals that the placenta could play an imperative role in schizophrenia and possibly other neurodevelopmental disorders.
In this research article from Journal of Comparative Effectiveness Research, a new network meta-analysis compares lurasidone and brexpiprazole in acute schizophrenia.